Wall Street Experts
ver. ZuMIgo(08/25)
Shin Nippon Biomedical Laboratories, Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 27 075
EBIT TTM (mln): 4 590
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
Rok finansowy |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Przychód (mln) |
12,296 |
13,805 |
17,289 |
19,647 |
19,540 |
19,050 |
17,372 |
15,274 |
17,154 |
16,926 |
17,835 |
14,750 |
17,244 |
16,601 |
15,659 |
14,561 |
15,111 |
17,748 |
25,091 |
Przychód Δ r/r |
0.0% |
12.3% |
25.2% |
13.6% |
-0.5% |
-2.5% |
-8.8% |
-12.1% |
12.3% |
-1.3% |
5.4% |
-17.3% |
16.9% |
-3.7% |
-5.7% |
-7.0% |
3.8% |
17.5% |
41.4% |
Marża brutto |
32.8% |
39.0% |
38.7% |
39.1% |
35.0% |
32.7% |
30.1% |
21.6% |
27.3% |
34.0% |
33.4% |
18.2% |
25.3% |
31.3% |
39.5% |
52.3% |
50.0% |
54.6% |
52.0% |
EBIT (mln) |
-329 |
772 |
1,126 |
1,586 |
464 |
344 |
-844 |
-3,049 |
-1,428 |
-724 |
-636 |
-3,863 |
-1,793 |
-697 |
830 |
2,228 |
2,530 |
4,196 |
5,245 |
EBIT Δ r/r |
0.0% |
-334.7% |
45.8% |
40.8% |
-70.7% |
-25.9% |
-345.4% |
261.4% |
-53.2% |
-49.3% |
-12.1% |
507.2% |
-53.6% |
-61.1% |
-219.0% |
168.5% |
13.5% |
65.9% |
25.0% |
EBIT (%) |
-2.7% |
5.6% |
6.5% |
8.1% |
2.4% |
1.8% |
-4.9% |
-20.0% |
-8.3% |
-4.3% |
-3.6% |
-26.2% |
-10.4% |
-4.2% |
5.3% |
15.3% |
16.7% |
23.6% |
20.9% |
Koszty finansowe (mln) |
150 |
178 |
178 |
252 |
284 |
343 |
343 |
309 |
302 |
307 |
290 |
304 |
378 |
374 |
378 |
235 |
185 |
127 |
125 |
EBITDA (mln) |
1,137 |
2,437 |
3,253 |
4,077 |
3,135 |
3,474 |
1,667 |
-160 |
1,187 |
1,771 |
1,837 |
3,282 |
526 |
1,170 |
3,423 |
4,241 |
5,018 |
8,705 |
10,920 |
EBITDA(%) |
9.3% |
17.6% |
18.8% |
20.7% |
16.0% |
18.2% |
9.6% |
-1.0% |
6.9% |
10.5% |
10.3% |
22.3% |
3.0% |
7.0% |
21.9% |
29.1% |
33.2% |
49.0% |
43.5% |
Podatek (mln) |
-17 |
309 |
434 |
264 |
413 |
-117 |
314 |
443 |
651 |
858 |
992 |
903 |
128 |
2,013 |
-308 |
415 |
498 |
1,016 |
1,709 |
Zysk Netto (mln) |
-472 |
267 |
544 |
600 |
-206 |
535 |
-1,442 |
-3,304 |
-1,153 |
-755 |
-1,386 |
2,646 |
-916 |
-3,556 |
1,950 |
2,550 |
3,662 |
7,128 |
6,060 |
Zysk netto Δ r/r |
0.0% |
-156.6% |
103.3% |
10.3% |
-134.3% |
-360.0% |
-369.8% |
129.1% |
-65.1% |
-34.5% |
83.5% |
-291.0% |
-134.6% |
288.2% |
-154.8% |
30.8% |
43.6% |
94.6% |
-15.0% |
Zysk netto (%) |
-3.8% |
1.9% |
3.1% |
3.1% |
-1.1% |
2.8% |
-8.3% |
-21.6% |
-6.7% |
-4.5% |
-7.8% |
17.9% |
-5.3% |
-21.4% |
12.5% |
17.5% |
24.2% |
40.2% |
24.2% |
EPS |
-29.96 |
8.28 |
15.83 |
17.46 |
-6.03 |
16.14 |
-43.26 |
-96.21 |
-33.57 |
-20.12 |
-34.84 |
66.52 |
-22.18 |
-85.41 |
46.85 |
61.26 |
87.96 |
171.21 |
145.57 |
EPS (rozwodnione) |
-29.96 |
8.28 |
15.83 |
17.46 |
-6.03 |
16.14 |
-43.26 |
-96.21 |
-33.57 |
-20.12 |
-34.84 |
66.52 |
-22.18 |
-85.41 |
46.85 |
61.26 |
87.96 |
171.21 |
145.57 |
Ilośc akcji (mln) |
16 |
32 |
34 |
34 |
34 |
33 |
33 |
34 |
34 |
38 |
40 |
40 |
41 |
42 |
42 |
42 |
42 |
42 |
42 |
Ważona ilośc akcji (mln) |
16 |
32 |
34 |
34 |
34 |
33 |
33 |
34 |
34 |
38 |
40 |
40 |
41 |
42 |
42 |
42 |
42 |
42 |
42 |
Waluta |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |
JPY |